Apatinib is a potent, selective vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor utilized primarily in the treatment of advanced or metastatic gastric cancer. Analytical… Read more









Apatinib is a potent, selective vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor utilized primarily in the treatment of advanced or metastatic gastric cancer. Analytical laboratories rely on high-quality reference standards of the Apatinib API, alongside its related compounds, to facilitate rigorous impurity profiling, method validation, and quality control. This category includes pharmacopeial and non-pharmacopeial impurities, such as N-nitroso derivatives, which are essential for monitoring synthesis by-products and degradation pathways. Furthermore, metabolic studies and mass spectrometry-based assays are supported by an array of metabolites, including hydroxy derivatives and glucuronide conjugates. The inclusion of stable isotope-labelled compounds, such as deuterium-labelled variants of Apatinib and its derivatives, provides internal standards necessary for achieving high accuracy and precision in complex quantitative analytical testing. These reference materials support the precise characterization of this anti-angiogenic therapeutic throughout its pharmaceutical development and regulatory lifecycle.